Start Submission Become a Reviewer

Reading: Economic Benefit-Cost Analysis of Select Secondary Prevention Interventions in LMIC

Download

A- A+
Alt. Display

Review

Economic Benefit-Cost Analysis of Select Secondary Prevention Interventions in LMIC

Authors:

Rachel Nugent ,

Department of Global Health, University of Washington, Seattle, WA, US
X close

Elizabeth Brouwer

Department of Global Health, University of Washington, Seattle, WA, US
X close

Abstract

We present a quantitative economic benefit-cost analysis of 2 secondary prevention targets that are part of the World Health Organization’s Global Monitoring Framework for noncommunicable diseases (NCD). These targets are expected to contribute to the achievement of the overall NCD target proposed for the Post-2015 Sustainable Development Goal Framework. We estimate that interventions would need to avert roughly 6 million to 7 million NCD deaths worldwide in 2030 to meet the target. We calculate that the combination of tobacco taxation that achieves 50% reduction in use and 70% coverage of high-risk populations with a multidrug regimen can provide one-half of that mortality reduction in 2030, at a benefit-cost ratio of 7:1, or U.S. $7 in benefits for each U.S. $1 in cost.</ce:simple-para>

Highlights

  • Secondary prevention interventions in LMICs are economically beneficial.
  • Two attractive interventions can provide one-half of the reduced NCD mortality target for 2030.
How to Cite: Nugent R, Brouwer E. Economic Benefit-Cost Analysis of Select Secondary Prevention Interventions in LMIC. Global Heart. 2015;10(4):319–21. DOI: http://doi.org/10.1016/j.gheart.2015.09.002
10
Views
12
Downloads
3
Citations
Published on 01 Dec 2015.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus